PPBT

Purple Biotech
PPBT

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $225K invested in Purple Biotech in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$97K
2
+$57K
3
+$47K

Top Sellers

1
-$70.9K
2
-$47K
3
-$31K
4
UBS Group
UBS Group
Switzerland
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$97K
2
$57K
3
$47K
4
$17K
5
$5K
6
$2K
7
–
8
–